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The negative-sense segmented RNA genome of influenza virus is transcribed into capped and polyadenylated
mRNAs, as well as full-length replicative intermediates (cRNAs). The mechanism that regulates the two forms
of transcription remains unclear, although several lines of evidence imply a role for the viral nucleoprotein (NP).
In particular, temperature-shift and biochemical analyses of the temperature-sensitive viruses A/WSN/33 ts56
and A/FPV/Rostock/34/Giessen tsG81 containing point mutations within the NP coding region have indicated
specific defects in replicative transcription at the nonpermissive temperature. To identify the functional defect,
we introduced the relevant mutations into the NP of influenza virus strain A/PR/8/34. Both mutants were
temperature sensitive for influenza virus gene expression in transient-transfection experiments but localized
and accumulated normally in transfected cells. Similarly, the mutants retained the ability to self-associate and
interact with the virus polymerase complex whether synthesized at the permissive or the nonpermissive tem-
peratures. In contrast, the mutant NPs were defective for RNA binding when expressed at the nonpermissive
temperature but not when expressed at 30°C. This suggests that the RNA-binding activity of NP is required for
replicative transcription.
The influenza A virus genome consists of eight segments of
negative-sense single-stranded RNA, which encode 10 identi-
fied polypeptides. These polypeptides are expressed through
transcription of the virion-associated genomic RNAs (vRNA)
into capped and polyadenylated positive-sense mRNAs. The
59-cap structure is not synthesized de novo by virus enzymes
but is recycled along with 10 to 15 nucleotides from host cell
heterogeneous nuclear RNAs by endonucleolytic cleavage and
used to prime influenza virus transcription (36). The poly(A)
tail is generated by repetitive transcription of a short stretch of
uridines located 15 to 22 bases from the 59 end of the template,
beyond which processive transcription does not occur (28). The
non-template-directed 59 and 39 modifications to viral mRNAs
render them ineffective as substrates for the synthesis of new
vRNA segments. Progeny vRNAs are instead synthesized via a
replicative intermediate plus sense transcript (cRNA) that is
not capped, contains no host-cell sequences, and is not poly-
adenylated (reviewed in reference 24). Four viral proteins are
necessary and sufficient to carry out these processes (19); the
three subunits of an RNA-dependent RNA polymerase (the P
proteins PB1, PB2, and PA) and a single-stranded RNA-bind-
ing nucleoprotein (NP). Indeed, the functional form of the v-
and cRNA segments are always associated with these polypep-
tides to form ribonucleoprotein (RNP) structures, which are
thought to be composed of one copy of the trimeric polymer-
ase and approximately one NP polypeptide per 20 bases of
RNA (24). The mechanisms underlying viral mRNA transcrip-
tion are comparatively well understood. The polymerase com-
plex binds to the 59 end of the vRNA template (47) in a step
which activates cap recognition by the PB2 subunit (7). Sub-
sequent interaction with the 39 end of vRNA via a combination
of base-pairing between terminal inverted repeats (18) and
direct protein-RNA contacts with the PB1 subunit (25) acti-
vates endonuclease activity (15), which is possibly mediated
by the PB2 subunit (5, 42). PB1 then initiates transcription by
using the capped RNA fragment as a primer (Braam et al. [6]).
Polyadenylation is thought to occur because the polymerase
remains bound to the 59 sequences immediately upstream of
the polyuridine stretch, preventing processive transcription
through the latter region (38, 39, 47).
In contrast, the mechanisms which induce the influenza virus
polymerase to switch from transcribing mRNAs to making
replicative intermediate cRNAs remain relatively ill defined.
The form of RNP packaged into virions will only synthesize
mRNA in vitro (44), and although the same vRNA templates
are transcribed into cRNA after infection of cells, an initial
round of mRNA transcription and subsequent protein expres-
sion is essential (16). This transcriptional switch is likely to be
multifactorial: genetic evidence points to the involvement of
the viral polymerase (29), and the direct participation of host
cell proteins is a possibility (43). In addition, multiple lines of
genetic and biochemical evidence implicate the virus NP as a
major factor. Several conditional lethal virus mutants with le-
sions in the NP gene have been isolated that are specifically
defective for replicative transcription (22, 30, 40, 41, 46), and
infected cell extracts that synthesize c- and vRNA in vitro
depend on a supply of non-RNP-associated NP (3, 41). More-
over, by using a combination of the genetic and biochemical
approaches, Shapiro and Krug (41) showed that extracts from
cells infected with the mutant A/WSN/33 ts56 virus (containing
a lesion in the NP gene) synthesized m-, c- and vRNA in vitro
at the permissive temperature but only mRNA at the nonper-
missive temperature. Nevertheless, we do not understand the
molecular mechanisms by which NP functions in replicative
transcription.
NP is a multifunctional protein, capable of binding RNA
(37) and a variety of viral and cellular proteins, including itself
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(37), two of the three subunits of the viral polymerase (4),
cellular importin a (35), and filamentous actin (10). Since the
function of NP in mRNA transcription is genetically and bio-
chemically distinguishable from its replicative function, we
reasoned that the two roles might require different subsets
of the individual activities of the polypeptide. Moreover, iden-
tification of the NP functions required for genome replication
would be informative as to the mechanisms involved. We there-
fore examined the biochemical activities of mutant NP mole-
cules containing temperature-sensitive (ts) lesions which disrupt
replicative transcription. The ts mutations from A/WSN/33
(WSN) ts56 and A/FPV/Rostock/34 (FPV) tsG81 conferred
temperature sensitivity on the ability of the A/PR/8/34 NP to
support influenza virus gene expression, without affecting the
cellular localization or accumulation of the polypeptides. The
mutations did not affect the ability of the polypeptides to make
NP-NP or NP-P protein-protein contacts, but they did induce
ts RNA-binding activity. This suggests that the RNA-binding
activity of NP is essential for replicative transcription.
MATERIALS AND METHODS
Plasmids and protein expression. Plasmids containing the wild-type A/PR/8/34
PB1, PB2 PA and NP genes under the control of a bacteriophage T7 RNA
polymerase promoter (pKT1, -2, -3, and -5, respectively) or lacking a heterolo-
gous gene (pKT0) have previously been described (5, 10). Plasmids containing
the NP gene fused to either Escherichia coli maltose-binding protein (pMAL-
NP) or Schistosoma japonicum glutathione S-transferase (GST) (pGEX-NP)
have also been reported (10). Point mutations were introduced by using oligo-
nucleotide-directed mutagenesis according to standard procedures (23). Plasmid
pPB2CAT9 containing an antisense chloramphenicol acetyltransferase (CAT)
gene flanked by the 59- and 39-noncoding regions from influenza virus segment 1
was the generous gift of Mark Krystal. Rabbit polyclonal antisera directed
against influenza FPV RNPs or amino acids 340 to 498 of A/PR/8/34 NP have
already been described (10).
Radiolabelled NP polypeptides were synthesized by using a coupled in vitro
transcription-translation system (8). Rabbit reticulocyte lysate (Promega) was
supplemented with 0.6 mCi of [35S]methionine per ml, 2 U of T7 RNA polymer-
ase (Gibco-BRL) per ml, 3.3 mM MgCl2, 0.2 mM nucleoside triphosphates, and
20 to 100 mg of plasmid DNA per ml before incubation at 30 or 37°C for 90 min.
Xenopus laevis oocytes were maintained and microinjected with synthetic
mRNAs encoding the influenza virus P proteins (transcribed from plasmids pKT
1 to 3) as previously described (5, 9).
Maltose-binding protein (MBP) or MBP fused to NP (MBP-NP) were purified
from extracts of E. coli cultures containing plasmids pMAL-c2 (New England
Biolabs) or pMAL-NP (or mutant derivatives thereof) by affinity chromatogra-
phy on amylose resin columns (New England Biolabs) as previously described
(10). GST or GST fused to NP (GST-NP) were similarly obtained from E. coli
cultures containing plasmid pGEX-4T1 (Pharmacia) or plasmid pGEX-NP as
described earlier (10).
Transfection of tissue culture cells, transient replication assays, and indirect
immunofluorescence. CV1 or BHK cells were infected with recombinant vaccinia
viruses separately encoding the three subunits of the influenza virus polymerase
(PB1-, PB2-, and PA-VAC [45]) and bacteriophage T7 RNA polymerase (VTF7
[14]) at a multiplicity of infection of 5 of each virus for 2 h at 37°C. The cells were
washed three times with serum-free medium before transfection with plasmid
DNA encoding NP and pPB2CAT9 in vitro-transcribed RNA by using a cationic
liposome mixture (Lipofectin [GIBCO-BRL] or Escort [Sigma-Aldrich]) as pre-
viously described (10). After 20 to 24 h incubation at 30 to 31°C (the permissive
temperature [PT]) or 37°C (the nonpermissive temperature [NPT]), the cells
were lysed, and the accumulation of CAT polypeptide was measured by using a
commercial enzyme-linked immunosorbent assay (ELISA; Boehringer Mann-
heim). The NPT was defined as 37°C throughout these experiments because the
wild-type (WT) influenza virus components failed to produce detectable quan-
tities of CAT polypeptide in the transfection system at the more usual NPTs of
39.5 or 40.5°C (data not shown).
For immunofluorescence analysis, BHK cells on coverslips were infected with
VTF7 only and transfected with plasmid DNA as described above. After 4 h of
incubation at 31 or 37°C, the cells were washed with phosphate-buffered saline
(PBS) containing 1% newborn calf serum, fixed in PBS containing 4% formal-
dehyde, and stained for NP by using anti-RNP serum as previously described
(10). Fluorescence was viewed on an Olympus IX70 microscope, and images
were captured by using an Hamamatsu Colour Chilled 3CCD video camera.
RNA transcription and binding assays. For in vitro RNA binding assays, a
radiolabelled 178-nucleotide synthetic RNA target corresponding to segment 8
but with nucleotides 84 to 795 (inclusive) deleted, and a C-to-A transversion of
the penultimate base was generated by in vitro transcription of plasmid pKT8-
D3959 with bacteriophage T7 RNA polymerase in the presence of [a-32P]CTP
(100 mM; specific activity, 2 Ci/mmol) as previously described (10). Filter binding
assays were performed by incubating protein samples with 20 fmol of RNA (ca.
5,000 cpm) in 25 mM Tris-Cl (pH 7.6)–50 mM NaCl–5 mM MgCl2–0.5 mM
dithiothreitol–5% glycerol at room temperature for 20 min. The reaction mix-
tures were filtered under vacuum through nitrocellulose membrane equilibrated
in 20 mM Tris-Cl (pH 7.6)–50 mM NaCl and washed three times with 200 ml of
the same buffer. Bound radioactivity was quantified by liquid scintillation count-
ing. For UV cross-linking experiments, reactions were incubated for 20 min at
room temperature as described above before irradiation at 254 nm for 5 min at
an intensity of 4 mW/cm2 in a Spectronics Corporation XL-1500 UV cross-linker.
Free RNA was removed by digestion with 2 mg of RNase A per ml for 30 min at
room temperature before analysis by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and autoradiography.
Protein binding assays. For precipitation reactions, 1 ml of in vitro-translated
protein or 2.5 ml of oocyte lysate (corresponding to one-quarter of an oocyte) was
incubated with 0.5 mg of fusion protein in 100 ml of IP buffer (100 mM KCl; 50
mM Tris-Cl, pH 7.6; 5 mM MgCl2; 1 mM dithiothreitol; 0.1% Nonidet P-40) for
1 h at room temperature. Then, 50 ml of a 50% (vol/vol) slurry of glutathione-
Sepharose (Pharmacia) or amylose resin (New England Biolabs) in PBS was
added as appropriate, and incubation continued for a further 30 min with gentle
mixing. The solid phase was collected by centrifugation and washed three times
with 750 ml of IP buffer. Bound material was eluted by boiling in 40 ml of SDS-
PAGE sample buffer and then analyzed by SDS-PAGE and autoradiography.
FIG. 1. Transcriptional activity and cellular accumulation of NP mutants. (A)
The ability of the indicated mutants to support virus gene expression at 31 or
37°C was measured by transfecting CV1 cells containing the influenza virus RNA
polymerase with plasmids pKT5, pKT5 S314-N, or A332-T and a synthetic
influenza RNA segment containing an antisense CAT gene and then measuring
the subsequent accumulation of CAT polypeptide. Data are plotted as the
percentage (with the standard error) of the value obtained with the WT gene,
and result from at least three independent determinations. (B) Cellular accu-
mulation of WT and mutant NPs. CV1 cells were transfected with plasmids
encoding WT NP (W), NP S314-N (S), NP A332-T (A), or plasmid vector
(pKT0) not containing a heterologous gene (2), maintained at the indicated
temperature for 6 h, detergent lysed, and examined for their NP content by
SDS-PAGE and Western blotting with an anti-NP serum. The position of NP is
indicated by the arrow.
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RESULTS
Induction of temperature sensitivity in the A/PR/8/34 strain
NP. For a functional study of the NPs of WSN ts56 and FPV
tsG81, we needed sources of recombinant protein. Although
we did not possess cDNA clones of the WT or mutant NP
genes from either virus strain, the ts lesions have been identi-
fied by comparison of the sequences of mutant and parental
viruses (26, 31). We therefore introduced the relevant muta-
tions into a cDNA clone of the influenza A/PR/8/34 (PR8)
strain NP (plasmid pKT5 [10]) to create plasmids pKT5 S314-
N and pKT5 A332-T. Although the WT WSN and FPV NP
amino acid sequences are closely related to that of PR8 (96
and 94% identical, respectively [26, 31, 50]), including identity
at residues 314 and 332, we examined the ts phenotype of the
mutations in the PR8 strain NP. To test the ability of the
mutant genes to support influenza virus gene expression, CV1
cells were infected with recombinant vaccinia viruses express-
ing the three influenza virus P proteins and bacteriophage T7
RNA polymerase and then were transfected with WT or mu-
tant pKT5 plasmids and an RNA containing an antisense CAT
gene flanked by the promoter sequences from influenza virus
segment 1 (PB2-CAT). After maintenance at either the PT
(31°C) or the NPT (37°C) for 20 h, the cells were lysed and the
accumulation of CAT polypeptide was measured (10). The
synthetic influenza virus segment was recognized by the WT
components of the virus transcriptase and transcribed and rep-
licated to yield CAT polypeptide expression (data not shown).
Figure 1 shows the activities of the mutants relative to the WT
gene at each temperature: the S314 polypeptide supported the
synthesis of essentially WT quantities of CAT at 31°C, while
the A332 mutant showed substantial activity, producing about
two-thirds the amount made in the presence of WT NP (Fig.
1A). However, the activity of both mutants was much reduced
at 37°C, producing on average less than 10% of the amount
seen with the WT gene (Fig. 1). Similar results were obtained
when the plasmids were titrated, with the mutants showing
equal temperature sensitivity at plasmid doses between 1 mg
and 10 ng/2 3 105 cells (data not shown). Thus, the mutations
confer temperature sensitivity on the transcriptional function
of PR8 strain NP. To ascertain whether the failure of the
mutants to support CAT synthesis at 37°C resulted from dif-
ferential stability of the mutants at the NPT, we analyzed
parallel transfections by SDS-PAGE and Western blotting with
an anti-NP serum. Both mutants expressed NP at levels similar
to those of the WT at 31 and 37°C and accumulated to higher
levels at 37°C (Fig. 1B). This indicates that the mutations do
not significantly affect the intracellular stability of either poly-
peptide.
FIG. 2. Cellular distribution of NP mutants. BHK cells (105) were transfected with 3 or 300 ng of plasmid and maintained for 4 h at 31 or 37°C as labelled. The
cells were formaldehyde fixed, detergent permeabilized, and examined for NP content by indirect immunofluorescence with an anti-RNP serum.
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Although NP contains at least two nuclear localization sig-
nals (34, 48, 49) and can localize to the nucleus in the absence
of other influenza virus proteins (27), more recent work has
shown that transiently expressed NP will accumulate in the
cytoplasm under certain circumstances (10, 34), similarly to the
late stages of authentic virus infection. We have shown that the
balance between nuclear import and cytoplasmic accumulation
is affected by the amount of NP expressed and its ability to bind
filamentous actin (10). We therefore examined the cellular
distribution of the mutants at the PT and NPT in cells trans-
fected with various amounts of plasmid by immunofluores-
cence with anti-NP serum. As with the WT gene (10), trans-
fection of cells with a low dose of plasmid (3 ng/105 cells)
resulted in predominantly nuclear accumulation of the mutant
polypeptides at the PT (Fig. 2b and f). Similarly, transfection of
cells at the PT with a high dose of plasmid (300 ng/105 cells)
resulted in substantial cytoplasmic accumulation of the poly-
peptides (Fig. 2a and e). This pattern of localization was not
substantially altered at the NPT, with both mutants still local-
izing to the nucleus when expressed in low abundance (Fig. 2d
and h) and to the cytoplasm when expressed at high level (Fig.
2c and g). Thus, neither ts lesion prevents the polypeptide from
localizing normally within the cell.
Having established that the mutant NPs displayed the ex-
pected ts phenotype and having ruled out failure to express or
localize to the nucleus as a cause of the defect, we went on to
assay individual biochemical functions of the polypeptides. The
mutant NP genes were subcloned into plasmid pMAL-NP to
allow the expression and affinity purification of MBP-NP fu-
sion proteins from E. coli as previously described (10). Non-
fused MBP was prepared from bacteria grown at 37°C, while
the WT and mutant fusion proteins were prepared from cul-
tures incubated at 30 or 37°C. By comparison with WT MBP-
NP, which expressed well and copurified with only small
amounts of a presumably proteolyzed MBP-NP “stub” (Fig. 3,
lane 1 [10]), the mutants contained greater quantities of the
contaminating shorter polypeptide. However, the ratios of full-
length fusion protein to degradation product were not dramat-
ically different between the preparations made at the PT or
NPT (Fig. 3, compare lanes 3 and 4 and lanes 5 and 6). In
addition, the MBP-NP stub contains only a short NP sequence
(compare mobilities with MBP, lane 2) that does not possess
detectable RNA binding (see below), oligomerization, or poly-
merase-binding properties (data not shown) and can therefore
be disregarded.
Recently, we have determined that in vitro-translated NP
binds to NP fusion proteins in a specific and quantitative man-
ner (12). We used this method to test whether the mutant NP
polypeptides were defective for NP-NP interactions. Radiola-
belled WT NP, NP S314-N, and NP A332-T were prepared by
in vitro transcription and translation of the appropriate plas-
mids in rabbit reticulocyte lysate at the NPT and then tested
for their ability to bind immobilized MBP or WT and mutant
MBP-NP fusion proteins in a binding assay. Substantial quan-
tities of WT NP translated in vitro bound to WT MBP-NP but
not to MBP (Fig. 4, lanes 2 and 3), indicating a specific inter-
action between the two NP moieties. However, similar quan-
tities of WT NP were bound by the mutant MBP-NP fusion
proteins irrespective of whether they were synthesized at the
permissive or nonpermissive temperature (lanes 4 to 7). More-
over, the mutant MBP-NP molecules showed little or no tem-
perature dependence in their ability to bind the homologous in
vitro-translated mutant (lanes 8 to 15). Thus, the ts lesions
have no significant effect on NP oligomerization.
While this study was in progress, Biswas et al. (4) published
experiments showing that NP was capable of forming direct
protein-protein contacts with the influenza virus polymerase.
We also find that NP binds the virus RNA polymerase. Previ-
ously, we have shown that the three influenza virus P proteins
assemble into a complex in X. laevis oocytes microinjected with
the appropriate synthetic mRNAs and that this system pro-
vides a convenient source of soluble radiolabelled protein for
binding studies (5, 9). When lysates from oocytes microinjected
with mRNAs encoding all three P proteins were incubated with
GST-NP and glutathione-Sepharose, all three P proteins be-
came associated with the solid phase (Fig. 5A, lane 3). The
precipitation was specific, since the majority of the cellular
polypeptides did not bind GST-NP (cf. lanes 1 and 3), and no
polypeptides were bound by immobilized GST (lane 2). Thus,
NP interacts with the polymerase complex. To determine
which of the polymerase subunits NP interacted with, we mi-
croinjected oocytes with mRNAs encoding the individual P
proteins and assayed the resulting lysates for binding to GST
or GST-NP. Both PB1 and PB2 were precipitated by GST-NP
but not by GST (lanes 5, 6, 8, and 9) but, in contrast, PA failed
to bind to either protein (lanes 11 and 12). Therefore, in
agreement with the findings of Biswas et al. (4), NP interacts
with the two basic P proteins but shows much less affinity for
PA. Accordingly, we went on to test the ability of the ts NP
mutants to bind the polymerase complex. Oocyte lysates con-
taining the three P proteins were incubated with MBP, WT
MBP-NP, or the mutant MBP-NP polypeptides prepared at
the PT or NPT and amylose resin; the solid phase was col-
lected, washed, and examined by SDS-PAGE and autoradiog-
raphy. All three P proteins, including PA (confirmed by West-
ern blot analysis [data not shown]), were precipitated by
MBP-NP but not by MBP alone (Fig. 5B, lanes 1 and 2),
indicating that NP fused to MBP also interacts with the poly-
merase complex. Similar quantities of the P proteins were
precipitated by the mutant MBP-NP proteins, with no obvious
differential activity between polypeptides prepared at 30 or
37°C (lanes 3 to 6). In addition, no differences were found
between the abilities of WT and ts mutant MBP-NP fusion
proteins to interact with PB1 or PB2 alone (data not shown).
Therefore, the ts lesions do not affect the ability of NP to bind
the influenza virus polymerase.
Previously, we have shown that MBP-NP (grown at 37°C)
binds RNA with an affinity similar to that of authentic NP
FIG. 3. Expression and purification of WT and mutant NP fusion proteins.
Lysates from E. coli cultures containing plasmids encoding WT MBP-NP (WT),
MBP-NP A332-T (A332), MBP-NP S314-N (S314), or MBP were grown at the
indicated temperatures and fractionated over amylose resin columns. Bound
proteins were eluted by the addition of maltose, dialyzed, and analyzed by
SDS-PAGE and stained with Coomassie brilliant blue dye. Also indicated are the
sizes of molecular mass markers (in kilodaltons).
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purified from virions and that MBP does not possess measur-
able binding activity (10). We tested the effects of growth and
assay temperature on WT MBP-NP by preparing protein at 30
or 37°C and then titrating the polypeptides’ RNA binding
activities at the two temperatures. At ca. 20 nM MBP-NP
grown at 37°C was required to retain 50% of a 1 nM solution
of a radiolabelled RNA on nitrocellulose filters at 37°C (Fig.
6a), which under the assay conditions corresponds to an esti-
mate of the dissociation constant of the interaction (10). The
binding curves derived from MBP-NP grown at 37°C and as-
sayed at 30°C or from MBP-NP grown at 30°C and assayed
at either temperature were essentially indistinguishable (Fig.
6A). In replicate experiments, the MBP-NP:RNA dissociation
constants for protein grown at 30 or 37°C and assayed at 37°C
were found to be 14.7 6 5.2 and 16.7 6 7.0 nM, respectively
(n 5 3), which is in good agreement with the values previously
measured for MBP-NP at room temperature (10) or for au-
thentic NP at 37°C (2). Thus, the RNA-binding activity of WT
MBP-NP is invariant over the PT and NPT ranges used here.
Next, we compared the RNA-binding activities of the mutant
polypeptides to WT MBP-NP by using a UV cross-linking
assay. The protein preparations (containing equal amounts
of full-length MBP-NP) were incubated with a radiolabelled
RNA at either 30 or 37°C, UV irradiated, incubated with
RNase to degrade unbound RNA, and analyzed by SDS-
PAGE and autoradiography to detect covalently bound RNA.
As expected, the WT polypeptide became radiolabelled at 30
and 37°C, indicating that it bound the RNA at either temper-
ature (Fig. 6B, lanes 1 and 7). No radiolabelled product was
seen in reactions containing MBP (lanes 2 and 8), nor was any
radiolabel acquired by MBP-NP in the absence of UV irradi-
ation (data not shown). If synthesized at 30°C, the full-length
S314 and A332 polypeptides bound RNA similarly to WT
MBP-NP when assayed at either 30 or 37°C, while no activity
was seen from the smaller MBP-NP “stub” (Fig. 6b, lanes 3, 5,
9, and 11). However, when synthesized at 37°C, the polypep-
tides displayed greatly reduced binding activity at either assay
temperature (lanes 4, 6, 10, and 12). Thus, the S314 and A332
mutations render the RNA-binding activity of NP temperature
sensitive. However, if synthesized at the PT, the polypeptides
are functional at the NPT. To further examine this aspect, we
compared the thermal stability of the RNA-binding activity of
the mutant and of the WT MBP-NP polypeptides. Samples
containing 1 nM radiolabelled RNA and 80 nM WT or A332
MBP-NP fusion protein (synthesized at 30°C) were incubated
at increasing temperatures, and aliquots were examined for
bound RNA by using a nitrocellulose filter binding assay. WT
MBP-NP showed slightly higher binding activity at 37 than at
30°C, but thereafter the binding decreased, reaching half the
original value at ca. 60°C, and it was largely lost by 80°C (Fig.
6c). The A332 mutant produced a binding curve essentially
indistinguishable from that of the WT protein, indicating no
significant change in the thermal stability of the mutant poly-
peptide. Similarly, no decrease in the relative stability was seen
with the S314 protein (data not shown). Thus, the S314 and
A332 polypeptides fail to bind RNA with high affinity if syn-
thesized at the NPT, but they possess thermostable binding
activity equal to that of the WT polypeptide if they are made at
the permissive temp.
FIG. 4. Oligomerization of NP mutants. Aliquots of WT, S314-N, or A332-T NP translated in vitro at 37°C were analyzed by SDS-PAGE and autoradiography
before (T) or after binding to MBP (2), WT MBP-NP (WT), or mutant MBP-NP fusion protein prepared at the indicated temperature.
FIG. 5. Ability of WT and mutant NP fusion proteins to bind influenza P
proteins. (A) Subunit specificity. Radiolabelled lysates from Xenopus oocytes
microinjected with synthetic mRNAs encoding the indicated P proteins (3P
corresponds to a mixture of PB1, PB2, and PA mRNAs) were analyzed by
SDS-PAGE and autoradiography before (T) or after precipitation with immo-
bilized GST (G) or GST-NP (N). The positions of the P proteins are marked by
arrows. The size of molecular mass markers are also indicated (in kilodaltons).
(B) Association of WT and mutant MBP-NP fusion proteins with the polymerase
complex. Radiolabelled lysates containing all three P proteins were analyzed as
described above after precipitation with MBP (M), WT MBP-NP (WT), or
mutant MBP-NP fusion proteins prepared at the indicated temperatures.
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DISCUSSION
The NP of influenza virus is required for the replicative
synthesis of viral RNAs. The ts mutations in WSN ts56 (S314-
N) and FPV tsG81 (A332-T) specifically disrupt replicative
transcription. If cells are infected with either virus at the per-
missive temperature for 3 to 5 h and then shifted to the NPT,
mRNA transcription continues but vRNA synthesis ceases (22,
40, 41). The synthesis of cRNA also ceases in ts56 (41), but it
is not known whether tsG81 behaves similarly. In addition, the
ts56 NP is unable to support c- or vRNA synthesis in vitro at
the NPT (41).
NP is a multifunctional protein and to identify activities
essential for replicative transcription, we have analyzed the
biochemical properties of engineered NP mutants which con-
tain the amino acid substitutions found in the ts56 and ts81
NPs. Here we show that the ts mutations S314-N and A332-T
render the RNA-binding activity of A/PR/8/34 NP temperature
sensitive (Fig. 6). The fact that the mutants showed apparently
WT RNA-binding activity and thermostability when synthe-
sized at 30°C but were defective when synthesized at 37°C
suggests that the mutations affect the folding of the polypep-
tide. However, the effect on RNA binding is specific, since the
mutations do not substantially alter the cellular accumulation
or distribution of the polypeptides (Fig. 1 and 2), suggesting
that the polypeptides interact with importin a, F-actin, and the
nuclear export machinery similarly to WT NP. Neither do the
mutations prevent the NP molecules from self-associating or
interacting with the virus polymerase normally (Fig. 4 and 5).
Further arguing against gross effects on polypeptide structure,
no significant differences were seen between the sensitivities of
the mutant and WT MBP-NP polypeptides to partial proteo-
lytic digestion with trypsin or chymotrypsin (data not shown).
Several hypotheses have been put forward to explain the
specific role of NP in the switch between mRNA and replica-
tive transcription. A recent suggestion concerns the ability of
NP to interact with the polymerase: in this model NP alters the
transcriptional function of the polymerase through direct pro-
tein-protein contacts (4, 33). In contrast, the encapsidation
hypothesis proposes that NP does not have a regulatory func-
tion as such and that other elements determine the choice
FIG. 6. RNA-binding activity of WT and mutant MBP-NP polypeptides. (A) Effect of growth and assay temperature on RNA-binding activity of WT MBP-NP.
Proteins were grown (G) at the indicated temperatures and titrated for their ability to bind and retain a radiolabelled RNA on nitrocellulose filters at the indicated
assay (A) temperature. (B) UV cross-linking assay. Equal amounts of MBP, WT, and mutant MBP-NP polypeptides (prepared at 30 or 37°C as labelled) were incubated
with radiolabelled RNA at the indicated temperatures and subjected sequentially to UV irradiation, RNase digestion, SDS-PAGE, and autoradiography. The positions
of MBP-NP, MBP, and the MBP-NP “stub” (as determined by staining of the gel with Coomassie brilliant blue [data not shown]) are indicated by arrows. (C) Thermal
denaturation of RNA-binding activity. WT or mutant A332-T MBP-NPs (the latter synthesized at 30°C) were incubated with radiolabelled RNA at increasing
temperatures, and aliquots were filtered through a nitrocellulose membrane to separate bound and free RNA. The bound values are plotted as a fraction of the amount
retained at 37°C.
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between cap-primed and unprimed transcription initiation but
that NP is required to cotranscriptionally coat the nascent c-
and vRNA segments (41). Alternatively, the template modifi-
cation hypothesis holds that the interaction of free NP (that is
not already present in the RNP structure) with the promoter
element of the template RNA alters the modes of transcription
initiation and termination (13, 18, 20). This is plausible, since
the terminal sequences of the vRNA template are partially
base paired to form a panhandle structure (2, 18), and recog-
nition of this structure by the polymerase is intimately con-
nected with the mechanisms of mRNA transcription initiation
(7, 15, 47) and polyadenylation (38, 39). Here we show that two
ts mutations which disrupt replicative transcription render the
RNA-binding activity of NP ts (Fig. 6), suggesting that NP-
RNA contacts are essential for the process. The encapsidation
and template modification hypotheses predict NP-RNA inter-
actions during RNA replication. Thus, our data support both
hypotheses but do not differentiate between the two. The
hypotheses are not necessarily exclusive, but further exper-
imental tests are necessary to determine whether one or both
mechanisms occur. In addition, the regulation of vRNA tran-
scription may differ from that of cRNA, and indeed genetic
evidence indicates that the roles of NP in c- and vRNA syn-
thesis are mutationally separable (33, 46). The role of NP in
vRNA synthesis is perhaps simpler, as cRNA templates do not
support cap-primed transcription or contain a polyadenylation
signal (7). Certainly, the premature termination of in vitro
vRNA transcription in the absence of soluble NP is consistent
with the necessity of NP for cotranscriptional encapsidation of
the nascent segment (41). The hypothesis that NP-P interac-
tions regulate transcription is not lent support by our results. In
addition, the competence of the ts NPs studied here to form
protein contacts with the influenza polymerase indicates that
NP-P interactions alone are not sufficient to support replicative
transcription. This is also supported by the observation that the
addition of excess NP to virion RNPs does not induce the
synthesis of cRNA (44). Although neither set of experiments
exclude the possibility that direct NP-P contacts are involved in
regulating the mode of transcription, it is also conceivable that
protein-protein contacts between NP and the polymerase play
a structural role during the assembly and transcription of RNPs.
Temperature-shift experiments carried out with ts56 and
tsG81 showed that mRNA transcription persisted at the NPT
(22, 40, 41). However, RNA-binding activity would also be
expected to be essential for mRNA synthesis, because NP is a
structural component of the RNP required for processive tran-
scription (17). The temperature stability of the RNA-binding
activity of mutant NPs made at the PT provides a plausible
explanation for the persistence of mRNA transcription, as
RNP cores made at 31°C would be predicted to retain full
functionality. However, we note that, in the experiments re-
ported by Shapiro and Krug (41), extracts from WSN ts56-
infected cells made at 31°C did not support replicative tran-
scription at 39.5°C, a finding which would not be predicted
from the temperature stability of our S314-N mutant. This
discrepancy might be explained by our using a lower NPT or,
alternatively, by the non-ts-associated sequence changes be-
tween the PR8 and WSN NPs.
The S314-N and A332-T mutations lie outside of the region
of NP previously identified as the minimal RNA-binding do-
main (approximately residues 1 to 180 [1, 21]). However, we
have recently determined that sequences throughout the
length of NP are in direct contact with RNA and have identi-
fied several other point mutations outside of the N-terminal
third of the polypeptide that similarly disrupt the interaction of
the protein with RNA (11). Thus, our current model is that
high-affinity RNA binding by NP requires the concerted func-
tion of multiple regions of the polypeptide.
Two further points arise from the tsG81/A332-T mutation. A
partial revertant of FPV tsG81A has been isolated that retains
the original ts NP gene, thus implying the extragenic suppres-
sion of the ts defect (32). The location of the suppressor mu-
tation was difficult to identify, but after a complex genetic study
Mandler and colleagues concluded that the mutation most
likely lay in the PB2 gene (32). We find no evidence of any
alteration in the ability of NP A332-T to interact with WT PB2,
either in the context of the polymerase complex (Fig. 6) or
alone (data not shown), but we have not studied NP binding to
the mutant PB2 isolated by Mandler et al. (32). Finally, a
recent study reported the effects of deliberately introduced NP
point mutations on m-, c-, and vRNA synthesis (33) in which
the authors mutated residue M331 (among others), adjacent to
the ts lesion in NP tsG81 (A332). Alteration to threonine had
little effect on NP function, but when it was changed to lysine,
the polypeptide became ts for gene expression and specifically
defective for cRNA synthesis (33). No further characterization
of the polypeptide was reported, but our results would predict
that NP M331-K has a ts RNA-binding activity similar to that
of NP A332-T.
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